Lebdai, Souhil <br/><br/>
What do we know about treatment sequencing of abiraterone, enzalutamide, and chemotherapy in metastatic castration-resistant prostate cancer?  [electronic resource] 

 -  World journal of urology  May 2016 
 - 617-24 p.  digital 
<br/><br/> Publication Type: Journal Article; Review; Systematic Review 
<br/><br/><label>ISSN: </label>1433-8726 
<br/><br/><label>Standard No.: </label>10.1007/s00345-015-1687-0  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Androstenes--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Benzamides<br/>Docetaxel<br/>Drug Resistance, Neoplasm<br/>Drug Therapy, Combination<br/>Humans<br/>Male<br/>Neoplasm Metastasis<br/>Nitriles<br/>Phenylthiohydantoin--administration & dosage<br/>Prostatic Neoplasms, Castration-Resistant--drug therapy<br/>Taxoids--administration & dosage